Events
Discovery and Development of M4K2009 for the Treatment of Diffuse Midline Glioma (DMG): An Open Science Approach
October 2, 2026 | 10:00 a.m.–11:45 a.m.
Leslie Dan Faculty of Pharmacy, Room 850, 144 College St., Toronto
Please note that this event is open to all; registration is not required.
Join the Centre for Preclinical Drug Development (CPDD) for a seminar with Dr. Peter Sampson, vice president of drug discovery and development at the Agora Open Science Trust. Dr. Sampson will discuss the discovery and development of M4K2009 as a potential treatment for diffuse midline glioma and the open science approach behind the program.
Dr. Peter Sampson
A medicinal chemist, Dr. Sampson has worked across drug discovery, chemistry, manufacturing and controls (CMC), regulatory affairs and the advancement of programs toward first-in-human clinical development.
Project Inquiry
Partner with CPDD through a collaborative, end-to-end process that moves from confidential consultation and expert project assessment to tailored study design, integrated preclinical research, and strategic decision-making support.